MTA2 (metastasis associated 1 family member 2)

2003-02-01  

Identity

HGNC
LOCATION
11q12.3
LOCUSID
ALIAS
MTA1L1,PID
FUSION GENES

Other Information

Locus ID:

NCBI: 9219
MIM: 603947
HGNC: 7411
Ensembl: ENSG00000149480

Variants:

dbSNP: 9219
ClinVar: 9219
TCGA: ENSG00000149480
COSMIC: MTA2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000149480ENST00000278823O94776
ENSG00000149480ENST00000278823A0A024R534
ENSG00000149480ENST00000524902O94776
ENSG00000149480ENST00000527204O94776

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Gene ExpressionREACTOMER-HSA-74160
Generic Transcription PathwayREACTOMER-HSA-212436
Transcriptional Regulation by TP53REACTOMER-HSA-3700989
RNA Polymerase I, RNA Polymerase III, and Mitochondrial TranscriptionREACTOMER-HSA-504046
RNA Polymerase I TranscriptionREACTOMER-HSA-73864
RNA Polymerase I Promoter ClearanceREACTOMER-HSA-73854
RNA Polymerase I Transcription InitiationREACTOMER-HSA-73762
Epigenetic regulation of gene expressionREACTOMER-HSA-212165
Chromatin organizationREACTOMER-HSA-4839726
Chromatin modifying enzymesREACTOMER-HSA-3247509
HDACs deacetylate histonesREACTOMER-HSA-3214815
Positive epigenetic regulation of rRNA expressionREACTOMER-HSA-5250913
Regulation of TP53 ActivityREACTOMER-HSA-5633007
Regulation of TP53 Activity through AcetylationREACTOMER-HSA-6804758
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expressionREACTOMER-HSA-427389

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
384740642024CircMTA2 Drives Gastric Cancer Progression through Suppressing MTA2 Degradation via Interacting with UCHL3.0
386491862024lncRNA LINC00941 modulates MTA2/NuRD occupancy to suppress premature human epidermal differentiation.0
384740642024CircMTA2 Drives Gastric Cancer Progression through Suppressing MTA2 Degradation via Interacting with UCHL3.0
386491862024lncRNA LINC00941 modulates MTA2/NuRD occupancy to suppress premature human epidermal differentiation.0
373714632023Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.2
373714632023Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.2
330958472021SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.12
333404312021MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.7
334203682021Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.7
337447622021Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells.2
337956512021MTA2 triggered R-loop trans-regulates BDH1-mediated β-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells.21
339585832021MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis.11
330958472021SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.12
333404312021MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.7
334203682021Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype.7

Citation

Dessen P

MTA2 (metastasis associated 1 family member 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/41444/cancer-prone-explorer/js/lib/js/hgnc